acinetobacter

(redirected from Acinetobacter infections)
Also found in: Medical, Encyclopedia.
Related to Acinetobacter infections: Acinetobacter baumannii

acinetobacter

(ˈæsɪnɪtʊˌbæktə)
n
(Microbiology) a bacterium that causes infections such as pneumonia, particularly in people who have a compromised immune system
[C20: from Greek acetinae immovable + bacter(ium)]
References in periodicals archive ?
According to our results, colistin seems to be the first treatment option in Acinetobacter infections in our unit.
2,18,19 Taken together, these results indicated that combinations with colistin and tigecycline remain the best choice for the treatment of MDR Acinetobacter infections.
Tahseen U, Talib MT Acinetobacter infections as an emerging threat in intensive care units.
It also reviews key players involved in the therapeutic development for Acinetobacter Infections and special features on late-stage and discontinued projects.
whereas the community- acquired Acinetobacter infections are associated more with renal failure, chronic lung disease, diabetes, alcoholism and smoking5.
6 For Pseudomonas and Acinetobacter infections, combining two antibiotics is often helpful.
Acinetobacter infections are uncommon and occur almost exclusively in hospitalised patients.
coli, Clostridium difficile infections, multi-drug resistant tuberculosis, Acinetobacter infections, infections due to NDM-1 (New Delhi metallo-beta-lactamase) producers, the Exserohilum rostratum incident, mucormycosis, Lyme borreliosis, Plasmodium knowlesi, measles, pertussis, and Buruli ulcer.
Acinetobacter infections have been treated with ampicillin, second-generation cephalosporins, carbenicillin, and gentamicin in recent years.
difficile) infection, an oral treatment to reduce the impact of methane producing organisms on constipation- predominant irritable bowel syndrome (C-IBS), a series of monoclonal antibodies for the treatment of Pertussis and Acinetobacter infections, and a biologic targeted at the prevention and treatment of a root cause of a subset of IBS.
It is sometimes used to denote resistance to three or more classes of drugs that would otherwise serve as treatments for Acinetobacter infections (e.
Multi-drug resistant Acinetobacter infections in critically injured Canadian forces soldiers.